CD4 + CD25 high CD127 low/-forkhead box p3 (Foxp3) + regulatory T cells (T reg cells) possess functional plasticity. Here we describe a higher frequency of T helper type 1 (T H 1)-like, interferon-γ (IFN-γ)-secreting Foxp3 + T cells in untreated subjects with relapsing remitting multiple sclerosis (RRMS) as compared to healthy control individuals. In subjects treated with IFN-β, the frequency of IFN-γ + Foxp3 + T cells is similar to that in healthy control subjects. In vitro, human T reg cells from healthy subjects acquire a T H 1-like phenotype when cultured in the presence of interleukin-12 (IL-12). T H 1-like T reg cells show reduced suppressive activity in vitro, which can partially be reversed by IFN-γ-specific antibodies or by removal of IL-12.
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Multiple sclerosis is a genetically mediated chronic inflammatory disease of the central nervous system (CNS). Activated CD4 + inflammatory cells in the circulation of affected individuals infiltrate into the CNS and damage both myelin and axons 1, 2 . A general loss of immune regulation is commonly seen in human autoimmune diseases [3] [4] [5] [6] .
In light of recent findings suggesting that Foxp3 + T reg cells show functional and phenotypic plasticity and are capable of secreting proinflammatory cytokines 7-9 , we were interested in analyzing ex vivo secretion of cytokines by T reg cells from individuals with relapsing/remitting multiple sclerosis (RRMS) that had not been receiving any immunomodulatory treatment as compared to age-matched healthy controls (Supplementary Methods and Supplementary Table 1) . We stimulated FACS-sorted CD4 + CD45RA -CD25 high CD127 low/-T reg cells (Supplementary Fig. 1a ) for 4 h with phorbol 12-myristate 13-acetate (PMA) and ionomycin. The percentage of T reg cells producing IFN-g was significantly higher in untreated individuals with RRMS as compared to healthy control individuals (Fig. 1a,b) . The frequency of T reg cells producing IL-17 did not differ between individuals with RRMS and control subjects. Analysis of the Foxp3 + T reg cell-specific demethylated region (TSDR) in sorted IFN-g + Foxp3 + and IFN-g -Foxp3 + multiple sclerosis T reg cells revealed that IFN-g-producing Foxp3 + T reg cells possessed a similar pattern of demethylation in the TSDR region to that of IFN-g -Foxp3 + T reg cells (Fig. 1c) and healthy control Foxp3 + T reg cells (data not shown).
After a 4-h stimulation with PMA and ionomycin, T reg cells isolated ex vivo from untreated subjects with RRMS showed a T H 1-like phenotype, including secretion of IFN-g, upregulation of mRNA expression of the T H 1-associated transcription factor TBET (encoded by TBX21) and downregulation of RORC (encoding RAR-related orphan receptor C) and TGFB1 (encoding transforming growth factor b1) mRNA ( Supplementary Fig. 2 and Supplementary Table 1) . CXCR3, but not CCR5 or IL10, was upregulated in T reg cells from subjects with RRMS as compared to healthy controls (Supplementary Fig. 2) . T reg cells from subjects with RRMS downregulated CTLA4 (encoding cytotoxic T lymphocyte-associated protein 4) (271.8 ± 86.9 (arbitary units) in controls compared to 43.91 ± 11.7 in RRMS T reg cells).
To ascertain whether IFN-g secretion by RRMS T reg cells reduces their suppressive activity, we cultured T reg cells and responder T cells ex vivo in the presence of an IFN-g-specific antibody. The suppressive activity of multiple sclerosis T reg cells was significantly increased upon IFN-g blockade, whereas healthy control T reg cells were not affected (Fig. 1d) .
IFN-b has been shown to affect the IL-12-IFN-g axis in people with multiple sclerosis 10 , among its other immunomodulatory effects. To examine the possible in vivo role of this axis in the generation of IFNg + Foxp3 + T cells in people with RRMS, we performed a cross-sectional investigation, isolating T reg cells from patients with RRMS treated for at least 1 year with IFN-b and comparing them to T reg cells from healthy control subjects. Intracellular staining revealed that the frequency of IFN-g + Foxp3 + T cells in IFN-b-treated subjects with RRMS was similar to that in age-and sex-matched healthy control subjects (Fig. 1e) . This was accompanied by an increase in the frequency of IL-17 + Foxp3 + T cells in IFN-b-treated patients with RRMS compared to healthy controls (Fig. 1e) . Although these alterations in cytokine release could be due to a direct effect of IFN-b on IL-17 secretion by T reg cells, IFNb-mediated decreases in the amount of IL-12 could also induce a change in the cytokine milieu, driving increased IL-17 production.
Individuals with autoimmune disease have elevated IL-12 expression, and T reg cells isolated from such individuals show reduced suppressive activity 3, 11, 12 . To elucidate the mechanism by which T reg cells produce IFN-g, we hypothesized that IL-12, a cytokine associated with T H 1 responses, would induce a T H 1-like phenotype in T reg cells, similar to the phenotype we observed ex vivo in T reg cells from subjects with RRMS. We cultured T reg cells from healthy control subjects in the presence or absence of IL-12. After 4 d, a significant (P = 0.009) percentage of IL-12-stimulated T reg cells secreted IFN-g ( Fig. 2a and Supplementary  Fig. 1b) . This increase was even more pronounced when we stimulated T reg cells from subjects with RRMS with IL-12 ( Supplementary  Fig. 1c) , suggesting a higher intrinsic responsiveness to IL-12 in these individuals.
The capacity of T reg cells from healthy subjects to secrete IFN-g was not accompanied by loss of Foxp3 expression (Supplementary Figs. 1d  and 3 ) and was dependent on the dose of IL-12 ( Supplementary Fig. 4) . IL-12 also induced a modest increase in IL-10, but not in IL-17 or IL-4, production ( Fig. 2a and Supplementary Fig. 5 ). Other members of the IL-12 family of cytokines, including IL-23 and IL-27, did not induce volume 17 | number 6 | june 2011 nature medicine IL-12-stimulated T reg cells expressed significantly more TBX21 mRNA and protein and less GATA3 mRNA as compared to T reg cells not treated with IL-12 ( Fig. 2b and Supplementary Fig. 9 ). There was no change in the expression of FOXP3, RORC, IRF1 (encoding interferon regulatory factor 1) and MAF, a transcription factor related to IL-10 production either IFN-g or IL-10 production (Supplementary Fig. 6 ). We confirmed at a single-cell level that IL-12 could induce IFN-g and IL-10 production in T reg cell clones (Supplementary Figs. 7 and 8) .
As expected given the induction of IFN-g secretion by IL-12, and similar to what we observed in ex vivo T reg cells from subjects with RRMS, ( Fig. 2b and Supplementary Fig. 9 ). We obtained similar results with single-cell-derived T reg cell clones stimulated for 10 d in the presence of IL-12 ( Supplementary Fig. 10 ).
To examine whether IL-12-stimulated Foxp3 + T-bet + T reg cells were functionally suppressive, we cocultured CD4 + CD25 low/-responder T cells with T reg cells that had been prestimulated for 4 d with IL-2 alone or with IL-2 and IL-12, along with antibody to CD3 and irradiated T cell-depleted peripheral blood mononuclear cells. After 3 d, T reg cells cultured with IL-2 and IL-12 were significantly less effective at inhibiting responder T cell proliferation as compared to IL-2-treated T reg cells (Fig. 2c and Supplementary Fig. 9c) . Blocking IFN-g increased the suppressive activity of T reg cells cultured with IL-2 and IL-12 but not that of control cells treated with only IL-2. These data suggest that other mechanisms may also account for the defect in suppression. We obtained the same results in antigen-presenting cell-free coculture assays (Supplementary Fig. 11 ). We also observed diminished suppressive activity of IL-12-treated T reg cell clones (Supplementary Fig.  12 ). Although our data point to a general defect in the suppressive activity of T H 1-like, Foxp3 + T cells, it is unclear whether these cells are able to specifically suppress T H 1 responses, as has been shown in a mouse model of inflammation 13 .
Next we examined the reversible nature of the T H 1-like T reg cell phenotype. We collected T reg cells cultured with IL-12 for 4 d and split them into two populations; one was washed to eliminate IL-12, whereas the other was cultured with IL-12 for 3 d longer. The frequency of IFN-g + Foxp3 + T cells decreased when we cultured the cells without IL-12 for the last 72 h, and these T reg cells reacquired suppressive activity ( Supplementary  Fig. 13 ). Viability staining of the populations excluded the possibility of selective apoptosis induced by the removal IL-12 (data not shown), suggesting that IL-12 did not induce permanent changes in the amount of IFN-g expressed or the frequency of T reg cells expressing IFN-g.
IL-12-stimulated T reg cells showed a T H 1 chemokine receptor profile 14, 15 characterized by expression of both CXCR3 and CCR5 and decreased TGFB1 mRNA and protein expression ( Fig. 2d and  Supplementary Fig. 14) . In contrast to T reg cells from subjects with RRMS, T reg cells upregulated CTLA4 mRNA and protein expression in response to IL-12 ( Supplementary Fig. 15) .
These data provide a general mechanism by which proinflammatory cytokines such as IL-12 can rapidly alter the phenotype and function of T reg cells, decreasing their suppressive activity. Our results suggest one b r i e f co m m u n i c at i o n s
